Andere Sprachen Alkem Laboratories Limited Bombay S.E.

Aktien

A2ACU0

INE540L01014

ALKEM

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:50 03.05.2024			% 5 Tage	% 1. Jan.
4 899 ^INR	+2,36 %		-0,04 %	-5,65 %

28.03.	Alkem Laboratories gründet Tochtergesellschaft für das Geschäft mit medizinischen Geräten	MT
28.03.	Alkem Laboratories Limited kündigt die Gründung der Tochtergesellschaft Alkem Medtech Private Limited an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak	16.04.
Alkem Laboratories Forms Subsidiary for Medical Devices Business	28.03.
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	28.03.
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection	28.03.
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy	12.02.
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	12.02.
Alkem Laboratories Limited Approves Interim Dividend for Financial Year 2023-24 , Payable on 1 March, 2024	09.02.
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09.02.
Research Update Biosergen: Licensing deal with Alkem and CTA submission	16.01.
Indian Equities Close Higher on Friday, Lifted by IT Stocks	12.01.
Alkem Laboratories Names Successor to Outgoing CFO	12.01.
Alkem Laboratories Limited Announces CFO Changes	12.01.
Heritage Global, Investors Acquire Pharmaceutical Plant from Alkem Laboratories	11.01.
Federal Machinery & Equipment Co., Heritage Global Partners, Inc., New Mill Capital LLC, Keith Machinery Corp acquired Pharmaceutical Site in Fenton Missouri from Alkem Laboratories Limited.	11.01.
Alkem Laboratories Limited Appoints Ashish Sehgal to Hold Senior Management Position in the Company Effective 15 December 2023	15.12.
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy	12.12.
Alkem Laboratories Limited Submits Clinical Trial Application to Central Drugs Standard Control Organization in India	12.12.
Alkem Laboratories Limited Submits Clinical Trial Application for First Patient Study with Bsg005 in Invasive Fungal Infections in India as A Rescue Therapy	12.12.
Biosergen's Indian Partner Seeks Approval for Clinical Trial of Antifungal Drug Candidate	12.12.
Alkem Laboratories Limited Appoints Kaustav Banerjee to Hold Senior Management Position	05.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Alkem Laboratories Limited Bombay S.E.

Aktien

A2ACU0

INE540L01014

ALKEM

Andere Sprachen

Filter